Trials / Completed
CompletedNCT04805606
A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
A Randomized, Open-label, and Parallel Study to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 in Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843
Detailed description
A Randomized, Open-label, and Parallel Study to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 in Male Volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-843 A | Single Dose |
| DRUG | CKD-843 B | Single Dose |
| DRUG | CKD-843-R | QD, PO |
Timeline
- Start date
- 2021-04-30
- Primary completion
- 2021-12-24
- Completion
- 2021-12-24
- First posted
- 2021-03-18
- Last updated
- 2022-04-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04805606. Inclusion in this directory is not an endorsement.